Pseudohyponatraemia in a patient with obstructive jaundice

Clinica Chimica Acta

Volumn 366, Issue 1-2, 2006, Pages 357-360

  Le Riche, Mia ^a   Burgess, Lesley J ^a   Marais, A David ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Lipoprotein X; Obstructive jaundice; Pseudohyponatraemia

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; HYPONATREMIA; LABORATORY TEST; LIVER FUNCTION TEST; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; PSEUDOHYPONATREMIA;

ADULT; DIAGNOSIS, DIFFERENTIAL; ELECTROPHORESIS, AGAR GEL; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPONATREMIA; JAUNDICE, OBSTRUCTIVE; LIPOPROTEIN-X;

EID: 33644677137     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.10.004     Document Type: Article

References (22)

1. L.S. Weisberg Pseudohyponatraemia: a reappraisal Am J Med 86 1989 315 318
2. M.J. Albrink, P.M. Hald, E.M. Man, and J.P. Peters The displacement of serum water by the lipids of hyperlipidemic serum. A new method for the rapid determination of serum water J Clin Invest 34 1955 1483 1488
3. R. Shakya, B.S. Rao, and B. Shrestha Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors Ann Pharmacother 38 2004 1074 1079
4. A. Turchin, D.A. Wiebe, E.W. Seely, T. Graham, W. Longo, and R. Soiffer Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver Bone Marrow Transplant 35 2005 85 89
5. J.C. Coakley, P.P. Vervaart, and M.R.G. McKay Factitious hyponatremia in a patient with cholestatic jaundice following bone marrow transplantation Pathology 18 1986 158 159
6. P.E. Hickman, K.P. Dwyer, and J.R.L. Masarei Pseudohyponatraemia, hypercholesterolaemia, and primary biliary cirrhosis J Clin Pathol 42 1989 167 171
7. G.T.C. Ko, V.T.F. Yeung, C.-C. Chow, T.W.L. Mak, and C.S. Cockram Pseudohyponatraemia secondary to hypercholesterolaemia Ann Clin Biochem 34 1997 324 325
8. J.T. Meredith Lipoprotein-X Arch Pathol Lab Med 110 1986 1123 1127
9. A. Ross, G.M. Murphy, P.A. Wilkinson, G.L. Mills, and S. Sherlock Occurrence of an abnormal lipoprotein in patients with liver disease Gut 11 1970 1035 1037
10. E. Manzato, R. Fellin, G. Baggio, S. Walch, W. Neubeck, and D. Seidel Formation of lipoprotein-X: its relationship to bile compounds J Clin Invest 57 1976 1248 1260
11. G. Baldo-Enzi, M.R. Baiocchi, and M. Grotto Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis: relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects Dig Dis Sci 33 10 1988 1201 1207
12. C.M. Edwards, M.P. Otal, and P.W. Stacpoole Lipoprotein-X fails to inhibit hydroxymethylglutaryl coenzyme A reductase in HepG2 cells Metabolism 42 7 1993 807 813
13. J.W. Chisholm, P. Nation, P.J. Dolphin, and L.B. Agellon High plasma cholesterol in drug-induced cholestasis is associated with enhanced hepatic cholesterol synthesis Am J Physiol 276 5 1999 G1165 G1173
14. P. Sörös, J. Böttcher, H. Maschek, O. Selberg, and M.J. Müller Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia Hepatology 28 1998 1199 1205
15. J.-L. Beaudeux, J. Peynet, and F. Flourie Discrepancies between lipoprotein(a) concentrations in icteric sera measured by immunonephelometry and electroimmunodiffusion Clin Biochem 27 1 1994 7 11
16. H. Fei, S. Maeda, and H. Kirii Evaluation of two different homogeneous assays for LDL-cholesterol in lipoprotein-X-positive serum Clin Chem 46 9 2000 1351 1356
17. J. Camps, J.M. Simó, S. Guaita, N. Ferré, and J. Joven Altered composition of lipoproteins in liver cirrhosis compromises three homogeneous methods for HDL-cholesterol Clin Chem 45 5 1999 685 688
18. X. Zhu, A.M. Herzenberg, and M. Eskandarian A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy Am J Pathol 165 2004 1269 1278
19. M. Guérin, P.J. Dolphin, and M.J. Chapman Familial lecithin : cholesterol acyltransferase deficiency: further resolution of lipoprotein particle heterogeneity in the low density interval Atherosclerosis 104 1993 195 212
20. M.M. Kaplan Primary biliary cirrhosis N Engl J Med 335 21 1996 1570 1580
21. H. Nagasaka, T. Yorifuji, and H.Z. Egawa Evaluation of risk for atherosclerosis in Alagille syndrome and progressive familial intrahepatic cholestasis: two congenital cholestatic diseases with different lipoprotein metabolisms J Pediatr 146 2005 329 335
22. P.-Y. Chang, S.-C. Lu, and T.-C. Su Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation J Lipid Res 45 2004 2116 2122